Covid booster jab not needed for everyone, says AstraZeneca vaccine creatorProactive Investors • 09/10/21
AstraZeneca's Imfinzi / Tremelimumab Combo Regime Shows Survival Benefit In Lung Cancer SettingsBenzinga • 09/09/21
AstraZeneca COVID-19 vaccine may trigger 'very rare' nerve disease, European regulator saysMarket Watch • 09/09/21
AstraZeneca asthma candidate passes clinical trials with flying coloursProactive Investors • 09/09/21
European Medicines Agency Lists Nerve Disorder As “Very Rare” Side Effect Of AstraZeneca Covid-19 VaccineForbes • 09/09/21
AstraZeneca's (AZN) Ultomiris Gets EU Nod for Rare Disease in KidsZacks Investment Research • 09/06/21
AstraZeneca's Ultomiris Scores European Nod For Rare Blood Disorder In Kids, AdolescentsBenzinga • 09/03/21
Covid Carries 'Much Higher' Blood Clot Risk Than Pfizer and AstraZeneca Vaccines: StudyBarrons • 08/27/21
AstraZeneca says ALXN1840 phase III trial in Wilson disease meets primary endpointProactive Investors • 08/26/21